Skip to main content Accessibility help
×
Home

LO33: Prehospital adverse events associated with nitroglycerin use in STEMI patients with right ventricle infarction

  • A.H. McConnell (a1), M. Davis (a1), K. Van Aarsen (a1), M. Columbus (a1) and M. Lewell (a1)...

Abstract

Introduction: Paramedics in our region do not perform 15-lead ECGs. As a result, patients experiencing a Right Ventricular Infarct (RVI) may receive nitroglycerin (NTG). In many cases, paramedics do not administer NTG to those with inferior STEMI out of concern that there may be an associated RVI. The purpose of this study is to determine if there is a difference in prehospital adverse events (AEs) associated with NTG administration in patients with unrecognized RVIs compared to those with an inferior STEMI and no RVI. Methods: Ambulance Call Records (ACR) of patients with prehospital STEMI between Jan 1, 2012 and Dec 31, 2015 were analyzed for the incidence of NTG administration. AEs were defined as HR<60 bpm, systolic BP <100 mmHg or drop of 1/3, GCS decrease of >2, syncope, arrest or death. Hospital records were reviewed to determine patients diagnosed with an inferior STEMI without RVI and those with a concurrent or primary RVI as diagnosed on angiography, ECG or discharge diagnosis. Results: Of the 334 ACRs that were filtered and manually reviewed, 144 were excluded (not STEMI, inter-facility transports, duplicate ACR) resulting in 189 patients that had a prehospital STEMI. The mean (SD) age was 66.9 (13.5) years and 70.6% were male. Of 189 STEMI patients, 82 (42.9%) received NTG. Nineteen (41.3%) of these patients were subsequently diagnosed with RVI and 27 (58.7%) had inferior STEMI without RVI. For patients receiving NTG, AEs occurred in 11 (57.9%) within the RVI group, and 10 (37.0%) within the inferior STEMI group (Δ 20.9%, 95% CI -7.8% to 45.4%, p=0.2). Cardiac arrest or death did not occur in either group. A total of 107 did not receive NTG and of these, 93 (86.9%) did not meet conditions or had contraindications for NTG use (22 RVI, 42 inferior STEMI). Three patients had a cardiac arrest and one died while in EMS care, none of which received NTG or had RVIs. Conclusion: Results of this study suggest no difference in the rate of AEs between patients with inferior STEMI and STEMI with RVI when NTG is administered in the prehospital setting. In our EMS system, the conditions and contraindications of NTG administration may be protective against AEs in RVIs, so the potential benefit of a prehospital 15-lead ECG may be limited.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      LO33: Prehospital adverse events associated with nitroglycerin use in STEMI patients with right ventricle infarction
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      LO33: Prehospital adverse events associated with nitroglycerin use in STEMI patients with right ventricle infarction
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      LO33: Prehospital adverse events associated with nitroglycerin use in STEMI patients with right ventricle infarction
      Available formats
      ×

Copyright

Corresponding author

*Corresponding authors

Keywords

LO33: Prehospital adverse events associated with nitroglycerin use in STEMI patients with right ventricle infarction

  • A.H. McConnell (a1), M. Davis (a1), K. Van Aarsen (a1), M. Columbus (a1) and M. Lewell (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed